While our previous data support a role of MK2 for enhancing angiogenesis under special conditions such as inflammation or tumour formation [9], the present data demonstrate that MK2 is not essential for normal angiogenesis at baseline. This evidence concerns the gene MAPKAPK2 and neoplasm.